Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 USD | -2.58% | +14.48% | -19.24% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.24% | 782M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4